Intratympanic plus systemic corticosteroids (combined therapy) vs systemic corticosteroids alone
Proportion of patients whose hearing is improved · sudden sensorineural hearing loss
It is very uncertain whether intratympanic plus systemic corticosteroids (combined therapy) changes proportion of patients whose hearing is improved compared with systemic corticosteroids alone (very low certainty).
2 findings from 1 review
- Intratympanic corticosteroids for sudden sensorineural hearing loss 2022 · Cochrane Headline outcomes onlyRR 1.27 [1.15, 1.41]10 studies · 788 participantsVery low
- Intratympanic corticosteroids for sudden sensorineural hearing loss 2022 · Cochrane Headline outcomes onlyRR 2.24 [1.1, 4.55]1 study · 76 participantsVery low